We are live on ! Find out more
CH

CVI Holdings Portfolio holdings

AUM $116M
1-Year Est. Return 5.68%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+5.68%
3 Year Est. Return
+25.77%
5 Year Est. Return
+327.29%
10 Year Est. Return
AUM
$1.48B
AUM Growth
+$32M
Cap. Flow
+$45.1M
Cap. Flow %
3.05%
Top 10 Hldgs %
12.82%
Holding
987
New
371
Increased
2
Reduced
19
Closed
197
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OPA.WS
426
DELISTED
Magnum Opus Acquisition Limited Redeemable Warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
OPA.WS
$315K 0.02%
+375,000
New +$245K
RMCOW icon
427
Royalty Management Holding Warrant
RMCOW
$314K 0.02%
+475,000
New +$240K
GXIIW
428
DELISTED
GX Acquisition Corp. II Warrant
GXIIW
$307K 0.02%
+333,333
New +$263K
TRONU
429
DELISTED
Corner Growth Acquisition Corp. 2 Units
TRONU
$302K 0.02%
+30,000
New +$303K
CRXTW
430
DELISTED
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
$300K 0.02%
400,000
KAHC.WS
431
DELISTED
KKR Acquisition Holdings I Corp. Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
KAHC.WS
$295K 0.02%
+250,000
New +$288K
AFAQW
432
DELISTED
AF Acquisition Corp Warrants
AFAQW
$293K 0.02%
+333,333
New +$254K
SCLE
433
DELISTED
Broadscale Acquisition Corp. Class A common stock
SCLE
$291K 0.02%
+30,000
New +$293K
ATMR.WS
434
DELISTED
Altimar Acquisition Corp II Warrants
ATMR.WS
$290K 0.02%
250,000
BENEW
435
DELISTED
Benessere Capital Acquisition Corp. Warrant
BENEW
$289K 0.02%
525,000
CPUH.WS
436
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$283K 0.02%
187,500
IGACW
437
DELISTED
IG Acquisition Corp. Warrant
IGACW
$280K 0.02%
250,000
PTOCW
438
DELISTED
Pine Technology Acquisition Corp. Warrant
PTOCW
$278K 0.02%
+333,333
New +$235K
FINMW
439
DELISTED
Marlin Technology Corporation Warrant
FINMW
$275K 0.02%
233,333
GSAH.WS
440
DELISTED
GS Acquisition Holdings Corp II Redeemable Warrants, each whole warrant exercisable for one share of
GSAH.WS
$275K 0.02%
125,000
GRNAW
441
DELISTED
GreenLight Biosciences Holdings, PBC Warrant
GRNAW
$273K 0.02%
250,000
HIIIW
442
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$269K 0.02%
+240,000
New +$227K
PPGHW
443
DELISTED
Poema Global Holdings Corp. Warrant
PPGHW
$267K 0.02%
350,000
SNPR.WS
444
DELISTED
Tortoise Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary shar
SNPR.WS
$267K 0.02%
123,053
BENER
445
DELISTED
Benessere Capital Acquisition Corp. Right
BENER
$266K 0.02%
700,000
SRNGW
446
DELISTED
Soaring Eagle Acquisition Corp. Warrant
SRNGW
$264K 0.02%
+80,000
New +$201K
IPOF.WS
447
DELISTED
Social Capital Hedosophia Holdings Corp. VI Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
IPOF.WS
$258K 0.02%
125,000
ABLLW
448
DELISTED
Abacus Life Warrant
ABLLW
$257K 0.02%
245,150
GOEVW
449
DELISTED
Canoo Inc. Warrant
GOEVW
$256K 0.02%
85,794
PUCKW
450
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$256K 0.02%
400,000

Similar funds

CVI Holdings's Q2 2021 Portfolio in Review

As of Q2 2021, CVI Holdings held 987 positions worth $1.48B, up 2.2% from $1.45B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

CVI Holdings deployed $45.1M of net new capital in Q2 2021, opening 371 new positions and adding to 2 existing holdings. Its largest new stake was FTAC Hera Acquisition Corp. Class A Ordinary Shares: 2,000,000 shares worth $19.5M.

By sector, the portfolio is most concentrated in Financials at 51% of assets, up from 24% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Nuvation Bio, an estimated $11M trimmed.

  • CVI Holdings's largest Q2 2021 buy was FTAC Hera Acquisition Corp. Class A Ordinary Shares: 2,000,000 shares worth $19.5M.
  • CVI Holdings added most to Blue Owl Capital in Q2 2021, an estimated $19.1M increase.
  • CVI Holdings's biggest Q2 2021 reduction was Nuvation Bio, cutting an estimated $11M.
  • CVI Holdings fully exited Piedmont Lithium Limited American Depositary Receipts in Q2 2021, selling an estimated $38.6M.
  • CVI Holdings's ten largest holdings make up 13% of its $1.48B portfolio in Q2 2021.
  • CVI Holdings opened 371 new positions and closed 197 in Q2 2021.
  • CVI Holdings's portfolio value rose 2.2% quarter-over-quarter to $1.48B.

Based on CVI Holdings's 13F filing for Q2 2021, filed 11 Aug 2021.